MX363258B - Compuestos piridinilpirazoloquinolina. - Google Patents

Compuestos piridinilpirazoloquinolina.

Info

Publication number
MX363258B
MX363258B MX2015013446A MX2015013446A MX363258B MX 363258 B MX363258 B MX 363258B MX 2015013446 A MX2015013446 A MX 2015013446A MX 2015013446 A MX2015013446 A MX 2015013446A MX 363258 B MX363258 B MX 363258B
Authority
MX
Mexico
Prior art keywords
formula
compound
pyridinylpyrazoloquinoline
group
represented
Prior art date
Application number
MX2015013446A
Other languages
English (en)
Spanish (es)
Other versions
MX2015013446A (es
Inventor
Norimine Yoshihiko
Takeda Kunitoshi
Ishihara Yuki
Sato Nobuaki
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of MX2015013446A publication Critical patent/MX2015013446A/es
Publication of MX363258B publication Critical patent/MX363258B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2015013446A 2013-04-05 2014-04-03 Compuestos piridinilpirazoloquinolina. MX363258B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361809118P 2013-04-05 2013-04-05
US201361809095P 2013-04-05 2013-04-05
PCT/JP2014/059852 WO2014163146A1 (ja) 2013-04-05 2014-04-03 ピリジニルピラゾロキノリン化合物

Publications (2)

Publication Number Publication Date
MX2015013446A MX2015013446A (es) 2016-01-12
MX363258B true MX363258B (es) 2019-03-19

Family

ID=51658437

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013446A MX363258B (es) 2013-04-05 2014-04-03 Compuestos piridinilpirazoloquinolina.

Country Status (20)

Country Link
US (1) US9550776B2 (de)
EP (1) EP2982674B1 (de)
JP (1) JP6244353B2 (de)
KR (1) KR102234131B1 (de)
CN (1) CN105189496B (de)
AU (1) AU2014250391B2 (de)
BR (1) BR112015024075B1 (de)
CA (1) CA2904820C (de)
CL (1) CL2015002837A1 (de)
ES (1) ES2654094T3 (de)
HK (1) HK1219100A1 (de)
IL (1) IL241695B (de)
MX (1) MX363258B (de)
PE (1) PE20151718A1 (de)
PH (1) PH12015502178A1 (de)
RU (1) RU2655172C2 (de)
SG (1) SG11201507733YA (de)
TW (1) TW201439091A (de)
WO (1) WO2014163146A1 (de)
ZA (1) ZA201507044B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201406486D0 (en) 2014-04-10 2014-05-28 Redx Pharma Ltd Antibacterial compounds
WO2017046606A1 (en) * 2015-09-18 2017-03-23 Redx Pharma Plc Antibacterial compounds
BR112019023552A2 (pt) 2017-06-01 2020-06-02 Eisai R&D Management Co., Ltd. Agente terapêutico para a demência com corpos de lewy contendo derivado de pirazoloquinolina
TWI802591B (zh) 2017-09-14 2023-05-21 日商第一三共股份有限公司 具有環狀構造的化合物
WO2021150613A1 (en) 2020-01-20 2021-07-29 Incyte Corporation Spiro compounds as inhibitors of kras
WO2021231526A1 (en) 2020-05-13 2021-11-18 Incyte Corporation Fused pyrimidine compounds as kras inhibitors
US11767320B2 (en) 2020-10-02 2023-09-26 Incyte Corporation Bicyclic dione compounds as inhibitors of KRAS
AU2022367432A1 (en) 2021-10-14 2024-05-02 Incyte Corporation Quinoline compounds as inhibitors of kras

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05132484A (ja) 1991-04-26 1993-05-28 Otsuka Pharmaceut Factory Inc ピラゾロキノリン及びピラゾロナフチリジン誘導体
DE69518075T2 (de) 1994-05-24 2001-03-22 Hoffmann La Roche Tricyclische dicarbonylderivate
DE102004004142A1 (de) * 2003-05-09 2004-11-25 Bayer Healthcare Ag 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine
US20060035920A1 (en) 2004-05-28 2006-02-16 Millennium Pharmaceuticals, Inc. Chk-1 inhibitors
JP2006045118A (ja) 2004-08-04 2006-02-16 Mochida Pharmaceut Co Ltd 新規ピラゾロキノロン誘導体
AU2006289838B2 (en) 2005-09-15 2011-08-18 Aska Pharmaceutical Co., Ltd. Heterocyclic compound, and production process and use thereof
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
US8299080B2 (en) 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
GEP20125405B (en) 2007-05-11 2012-02-27 Pfizer Amino-heterocyclic compounds
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
PL2404922T3 (pl) * 2009-03-05 2017-03-31 Astellas Pharma Inc. Związki chinoksalinowe
MX2011010184A (es) 2009-03-31 2011-10-28 Boehringer Ingelheim Int Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4 -ona y su uso como moduladores de pde9a.
JP5888237B2 (ja) * 2010-09-07 2016-03-16 アステラス製薬株式会社 ピラゾロキノリン化合物
PL2573073T3 (pl) 2011-09-26 2015-04-30 Sanofi Sa Pochodne pirazolochinolinonu, ich wytwarzanie i ich zastosowanie terapeutyczne
JP6042060B2 (ja) 2011-09-26 2016-12-14 サノフイ ピラゾロキノリノン誘導体、その調製および治療上の使用
RU2605096C2 (ru) * 2011-10-07 2016-12-20 ЭЙСАЙ АрЭНДДи МЕНЕДЖМЕНТ КО., ЛТД. Пиразолохинолиновое производное

Also Published As

Publication number Publication date
CN105189496B (zh) 2017-03-29
US20160289225A1 (en) 2016-10-06
RU2015140669A3 (de) 2018-03-21
PE20151718A1 (es) 2015-11-22
KR102234131B1 (ko) 2021-04-01
US9550776B2 (en) 2017-01-24
BR112015024075A2 (pt) 2017-10-24
RU2015140669A (ru) 2017-05-11
EP2982674A1 (de) 2016-02-10
AU2014250391B2 (en) 2017-11-02
ZA201507044B (en) 2017-02-22
SG11201507733YA (en) 2015-10-29
HK1219100A1 (zh) 2017-03-24
CA2904820C (en) 2021-05-18
EP2982674A4 (de) 2016-08-31
IL241695B (en) 2019-06-30
BR112015024075B1 (pt) 2022-05-03
WO2014163146A1 (ja) 2014-10-09
JP6244353B2 (ja) 2017-12-06
CN105189496A (zh) 2015-12-23
MX2015013446A (es) 2016-01-12
PH12015502178A1 (en) 2016-01-25
CA2904820A1 (en) 2014-10-09
CL2015002837A1 (es) 2016-04-22
EP2982674B1 (de) 2017-10-25
TW201439091A (zh) 2014-10-16
KR20150138204A (ko) 2015-12-09
AU2014250391A1 (en) 2015-10-15
ES2654094T3 (es) 2018-02-12
JPWO2014163146A1 (ja) 2017-02-16
RU2655172C2 (ru) 2018-05-24

Similar Documents

Publication Publication Date Title
PH12015501993A1 (en) Pyrazole-amide compound and medicinal uses therefor
PH12015502178A1 (en) Pyridinylpyrazoloquinoline compound
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
IN2015DN01035A (de)
MX361499B (es) Baricitinib deuterado.
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
UA116395C2 (uk) ПОХІДНІ ТРИАЗОЛ[4,5-b]ПІРИМІДИНУ
UA118666C2 (uk) Похідні піразолу
MX359825B (es) Compuesto pirazol y su uso farmaceutico.
PH12015500900B1 (en) A stabilized pemetrexed formulation
PH12015501588A1 (en) Compounds and methods for treating bacterial infections
AU2015211852A1 (en) Heterocyclic sulfonamide derivative and medicine comprising same
PH12015502665A1 (en) Improvements in or relating to organic compounds
MX363545B (es) Derivados piridin-4-ilo.
MX2015015755A (es) Derivados de perhidroquinoxalina utiles como analgesicos.
GB201305247D0 (en) Amide Compounds
IN2014DN10669A (de)
PH12015501146A1 (en) Hydantoin derivative
MX2015016766A (es) Nuevos derivados de tetrazolona.
IN2014DE01203A (de)
UA88023U (ru) Соединение 1,3-бис-(2-гидроксиэтил)-урацил с потенциальными физиологическими свойствами
UA87650U (uk) Сполука 1-(1',1'-дифтор-2'-бром-2'-хлоретил)-5-метилурацил з потенційними фізіологічними властивостями
UA87694U (uk) Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид з потенційними фізіологічними властивостями
UA87253U (ru) Соединение 1-(1',1'-дифтор-2'-бром-2'-хлорэтил)-урацил с потенциальными физиологическими свойствами
UA86446U (ru) Соединение 1,1'-(2"-бром-2"-хлорэтенил)-бис-(урацил) с потенциальными физиологическими свойствами